Korro Bio, Inc. — Director's Dealing 2025

Jun 12, 2025

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Korro Bio, Inc. (KRRO)
CIK: 0001703647
Period of Report: 2025-06-11

Reporting Person: Behbahani Ali (N/A)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2025-06-11	Stock Option (Right to Buy)	$14.87	A	6010	Acquired	2035-06-10	Common Stock (6010)	Direct

Footnotes

F1: The shares subject to the option vest in full on the earlier of (i) the one-year anniversary of the grant date or (ii) the date of the next annual meeting of stockholders, subject to continued service as a non-employee director through the applicable vesting date.